NL1000332C1 - Graduele chemische modificatie van biologisch actieve peptiden en eiwitten. - Google Patents

Graduele chemische modificatie van biologisch actieve peptiden en eiwitten.

Info

Publication number
NL1000332C1
NL1000332C1 NL1000332A NL1000332A NL1000332C1 NL 1000332 C1 NL1000332 C1 NL 1000332C1 NL 1000332 A NL1000332 A NL 1000332A NL 1000332 A NL1000332 A NL 1000332A NL 1000332 C1 NL1000332 C1 NL 1000332C1
Authority
NL
Netherlands
Prior art keywords
proteins
biologically active
chemical modification
active peptides
gradual chemical
Prior art date
Application number
NL1000332A
Other languages
English (en)
Inventor
Victor Smit
Original Assignee
Victor Smit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26642070&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL1000332(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from NL9401404A external-priority patent/NL9401404A/nl
Application filed by Victor Smit filed Critical Victor Smit
Priority to NL1000332A priority Critical patent/NL1000332C1/nl
Priority to ES95929258T priority patent/ES2208691T3/es
Priority to DE69531955T priority patent/DE69531955T2/de
Priority to EP95929258A priority patent/EP0796276B1/en
Priority to PCT/NL1995/000292 priority patent/WO1996006860A2/en
Priority to JP8508637A priority patent/JPH10507161A/ja
Priority to CA002198919A priority patent/CA2198919A1/en
Priority to AU32668/95A priority patent/AU3266895A/en
Priority to US08/807,506 priority patent/US20020150551A1/en
Publication of NL1000332C1 publication Critical patent/NL1000332C1/nl
Application granted granted Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NL1000332A 1994-08-31 1995-05-10 Graduele chemische modificatie van biologisch actieve peptiden en eiwitten. NL1000332C1 (nl)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NL1000332A NL1000332C1 (nl) 1994-08-31 1995-05-10 Graduele chemische modificatie van biologisch actieve peptiden en eiwitten.
US08/807,506 US20020150551A1 (en) 1994-08-31 1995-08-30 Gradual modification, super-agonists and antagonists of signal - proteins and peptides
EP95929258A EP0796276B1 (en) 1994-08-31 1995-08-30 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
DE69531955T DE69531955T2 (de) 1994-08-31 1995-08-30 PROGRESSIVE ANDERUNG VON SIGNAL-PROTEINEN UND PEPTIDEn UND DIE HERGESTELLTEN SUPERAGONISTEN UND ANTAGONISTEN
ES95929258T ES2208691T3 (es) 1994-08-31 1995-08-30 Modificacion gradual, superagonistas o antagonistas de proteinas y peptidos señal.
PCT/NL1995/000292 WO1996006860A2 (en) 1994-08-31 1995-08-30 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
JP8508637A JPH10507161A (ja) 1994-08-31 1995-08-30 シグナルタンパク質およびシグナルペプチドの段階的修飾、ならびにスーパーアゴニストおよびスーパーアンタゴニスト
CA002198919A CA2198919A1 (en) 1994-08-31 1995-08-30 Gradual modification, super agonists and antagonists of signs and peptides
AU32668/95A AU3266895A (en) 1994-08-31 1995-08-30 Gradual modification, super-agonists and antagonists of sinal-proteins and peptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9401404A NL9401404A (nl) 1994-08-31 1994-08-31 Graduele chemische modificatie van biologisch actieve peptiden en eiwitten.
NL1000332A NL1000332C1 (nl) 1994-08-31 1995-05-10 Graduele chemische modificatie van biologisch actieve peptiden en eiwitten.

Publications (1)

Publication Number Publication Date
NL1000332C1 true NL1000332C1 (nl) 1996-03-04

Family

ID=26642070

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1000332A NL1000332C1 (nl) 1994-08-31 1995-05-10 Graduele chemische modificatie van biologisch actieve peptiden en eiwitten.

Country Status (9)

Country Link
US (1) US20020150551A1 (nl)
EP (1) EP0796276B1 (nl)
JP (1) JPH10507161A (nl)
AU (1) AU3266895A (nl)
CA (1) CA2198919A1 (nl)
DE (1) DE69531955T2 (nl)
ES (1) ES2208691T3 (nl)
NL (1) NL1000332C1 (nl)
WO (1) WO1996006860A2 (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955807B1 (en) 1998-05-15 2005-10-18 Bayer Pharmaceuticals Corporation IL-2 selective agonists and antagonists
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
JP5097714B2 (ja) * 2005-12-12 2012-12-12 カンジ，インコーポレイテッド Ｅ１領域内の発現カセットと不活性化されたｅ２ｂポリメラーゼを有するアデノウイルス発現ベクター

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
AU598300B2 (en) * 1986-09-04 1990-06-21 Cetus Corporation Succinylated interleukin-2 for pharmaceutical compositions
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
DK0670898T3 (da) * 1992-11-24 2004-02-09 Searle & Co Interleukin-3 (IL-3)-mutantpolypeptider
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
US5658739A (en) * 1994-05-10 1997-08-19 The Regents Of The University Of California Method for characterization of the fine structure of protein binding sites
US5710252A (en) * 1995-02-03 1998-01-20 Eastman Kodak Company Method for recombinant yeast expression and isolation of water-soluble collagen-type polypeptides

Also Published As

Publication number Publication date
DE69531955D1 (de) 2003-11-20
EP0796276A1 (en) 1997-09-24
JPH10507161A (ja) 1998-07-14
WO1996006860A3 (en) 1996-07-18
AU3266895A (en) 1996-03-22
DE69531955T2 (de) 2004-07-29
EP0796276B1 (en) 2003-10-15
US20020150551A1 (en) 2002-10-17
ES2208691T3 (es) 2004-06-16
CA2198919A1 (en) 1996-03-07
WO1996006860A2 (en) 1996-03-07

Similar Documents

Publication Publication Date Title
ZA941771B (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
DE69526801D1 (de) Aerosolformulierungen mit peptiden und proteinen
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
DE69900746T2 (de) Gesteuerte verabreichung von peptiden oder proteinen
EP0950665A4 (en) PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
EP0785276A4 (en) MODIFICATION OF A PEPTIDE AND A PROTEIN
DE69424576D1 (de) Biologisch aktive tgf-beta1 und tgf-beta2 peptide
DE69325577D1 (de) Mn-gen und protein
GB9521544D0 (en) Activation of P53 protein and therapeutic applications thereof
AU3321595A (en) Recombinant production of biologically active peptides and proteins
ATE273031T1 (de) Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen
ZA9610721B (en) Grapevine leafroll virus proteins and their uses.
DE69520475D1 (de) Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen
HUP9901343A3 (en) P53 protein variants and therapeutical uses thereof
DE69123345T2 (de) Sequenzielle c-termin degradierung von peptiden und proteinen
ZA983239B (en) Stable active human ob protein compositions and methods
NL1000332C1 (nl) Graduele chemische modificatie van biologisch actieve peptiden en eiwitten.
AU8769791A (en) Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence
DE69529295D1 (de) Chemische proteindenaturierungsbehandlung
GB2336844B (en) Anti-hiv peptides and proteins
KR960010685A (ko) 펩티드 및 그 용도
EE9800108A (et) Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid
DE3869939D1 (de) Biologisch wirksame peptide.
DE69420044D1 (de) Blutregulierende peptide

Legal Events

Date Code Title Description
BV The patent application has lapsed
VD1 Lapsed due to non-payment of the annual fee

Effective date: 19991201